Literature DB >> 12925150

Gastric restitution is inhibited by dexamethasone, which is reversed by hepatocyte growth factor and rebamipide.

M Takahashi1, H Takada, K Takagi, S Kataoka, R Soma, H Kuwayama.   

Abstract

BACKGROUND: Glucocorticoids have been shown to induce peptic ulcers, especially when co-administered with NSAIDs. Hepatocyte growth factor (HGF) plays a role in gastric ulcer repair, facilitating the restitution of gastric mucosal epithelial cells. HGF expression is induced by PGs in gastric fibroblasts. We hypothesized that dexamethasone (DEX) may inhibit PG production and HGF expression, thus inhibiting HGF-induced gastric epithelial restitution. AIM: To investigate the effect of DEX on gastric restitution, using cultured gastric cells, the role of HGF in the restitution inhibited by DEX, and the effect of rebamipide on DEX- inhibited restitution.
METHODS: Human gastric fibroblasts were prepared from human stomach obtained at surgery; PGE2 and HGF is determined by ELISA; Restitution was assessed by the round wound restitution model, using coculture of gastric fibroblasts and epithelial cells; COX-2 and HGF mRNA were quantified by TaqMan RT-PCR system.
RESULTS: 1. DEX inhibited HGF mRNA and COX-2 mRNA. Accordingly, it inhibited PGE2 and HGF release. 2. DEX inhibited the restitution of gastric cells. 3. The inhibition of restitution was reversed by HGF and rebamipide to the same extent. 4. Rebamipide induced PGE2 and HGF.
CONCLUSION: DEX inhibits restitution via HGF depletion, and rebamipide reverses the inhibited restitution by HGF induction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12925150     DOI: 10.1046/j.1365-2036.18.s1.19.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

1.  Rebamipide promotes healing of colonic ulceration through enhanced epithelial restitution.

Authors:  Tomohisa Takagi; Yuji Naito; Kazuhiko Uchiyama; Toshimitsu Okuda; Katsura Mizushima; Takahiro Suzuki; Osamu Handa; Takeshi Ishikawa; Nobuaki Yagi; Satoshi Kokura; Hiroshi Ichikawa; Toshikazu Yoshikawa
Journal:  World J Gastroenterol       Date:  2011-09-07       Impact factor: 5.742

2.  Rebamipide enema is effective for treatment of experimental dextran sulfate sodium induced colitis in rats.

Authors:  Takako Nakashima; Takashi Maeda; Hisashi Nagamoto; Takeshi Kumakura; Masaaki Takai; Toyoki Mori
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

3.  Rebampide enema therapy as a treatment for patients with chronic radiation proctitis: initial treatment or when other methods of conservative management have failed.

Authors:  Tae Oh Kim; Geun Am Song; Sun Mi Lee; Gwang Ha Kim; Jeong Heo; Dae Hwan Kang; Mong Cho
Journal:  Int J Colorectal Dis       Date:  2008-03-08       Impact factor: 2.571

4.  Rebamipide suppresses TLR-TBK1 signaling pathway resulting in regulating IRF3/7 and IFN-α/β reduction.

Authors:  Naotaka Ogasawara; Makoto Sasaki; Yukimi Itoh; Kentaro Tokudome; Yoshihiro Kondo; Yoshitsugi Ito; Satoshi Tanida; Takeshi Kamiya; Hiromi Kataoka; Takashi Joh; Kunio Kasugai
Journal:  J Clin Biochem Nutr       Date:  2011-02-26       Impact factor: 3.114

5.  Enhancement of Gastric Ulcer Healing and Angiogenesis by Hepatocyte Growth Factor Gene Mediated by Attenuated Salmonella in Rats.

Authors:  Xiaoqin Ha; Junhua Peng; Hongbin Zhao; Zhiyun Deng; Juzi Dong; Hongyan Fan; Yong Zhao; Bing Li; Qiangsheng Feng; Zhihua Yang
Journal:  J Korean Med Sci       Date:  2017-02       Impact factor: 2.153

6.  Medroxyprogesterone acetate inhibits wound closure of human endometrial epithelial cells and stromal fibroblasts in vitro.

Authors:  Mickey V Patel; Marta Rodriguez-Garcia; Zheng Shen; Charles R Wira
Journal:  Sci Rep       Date:  2021-12-01       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.